These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1841774)

  • 21. [Modification of coronary arteriosclerosis in man by calcium antagonists?].
    Schneider W; Roebruck P; Cieslinski G; Noack H; Kober G; Alle M; Kaltenbach M
    Z Kardiol; 1991; 80 Suppl 9():63-71. PubMed ID: 1796651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem on complications and restenosis after coronary angioplasty.
    O'Keefe JH; Giorgi LV; Hartzler GO; Good TH; Ligon RW; Webb DL; McCallister BD
    Am J Cardiol; 1991 Feb; 67(5):373-6. PubMed ID: 1994661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
    Waters D; Lespérance J
    Circulation; 1992 Dec; 86(6 Suppl):III111-6. PubMed ID: 1424044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.
    Hillegass WB; Ohman EM; Leimberger JD; Califf RM
    Am J Cardiol; 1994 May; 73(12):835-9. PubMed ID: 8184803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Frankfurt experience in restenosis after coronary angioplasty.
    Bussmann WD; Kaltenbach M; Kober G; Vallbracht C
    Am J Cardiol; 1987 Jul; 60(3):48B-49B. PubMed ID: 2956842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty.
    Urban P; Buller N; Fox K; Shapiro L; Bayliss J; Rickards A
    Br Heart J; 1988 Dec; 60(6):485-8. PubMed ID: 2975949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical approaches to prevention of restenosis after coronary angioplasty.
    Blackshear JL; O'Callaghan WG; Califf RM
    J Am Coll Cardiol; 1987 Apr; 9(4):834-48. PubMed ID: 2951423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.
    Whitworth HB; Roubin GS; Hollman J; Meier B; Leimgruber PP; Douglas JS; King SB; Gruentzig AR
    J Am Coll Cardiol; 1986 Dec; 8(6):1271-6. PubMed ID: 2946740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty.
    Kanzaki H; Miyazaki S; Noguchi T; Yasuda S; Sumida H; Daikoku S; Morii I; Itoh A; Goto Y; Nonogi H
    Jpn Heart J; 1999 Jan; 40(1):11-21. PubMed ID: 10370393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
    Roberts R
    Postgrad Med; 1988 Jan; 83(1):249-56. PubMed ID: 3275938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?
    Schneider W; Kober G; Roebruck P; Noack H; Alle M; Cieslinski G; Reifart N; Kaltenbach M
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S17-23. PubMed ID: 2261941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B
    Eur Heart J; 1989 Dec; 10 Suppl G():64-8. PubMed ID: 2697565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.
    Vahanian A; Lung B
    Drugs; 1996; 52 Suppl 4():9-15; discussion 15-6. PubMed ID: 8913714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms whereby calcium channel antagonists may protect patients with coronary artery disease.
    Opie LH
    Eur Heart J; 1997 Jan; 18 Suppl A():A92-104. PubMed ID: 9049544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
    Messerli FH; Michalewicz L
    Am Heart J; 1997 Aug; 134(2 Pt 2):S21-4. PubMed ID: 9313620
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardioplegia and calcium antagonists: a review.
    de Jong JW
    Ann Thorac Surg; 1986 Nov; 42(5):593-8. PubMed ID: 2946269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.